Cardiff University-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Cardiff University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011826
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Cardiff University is an educational institute that provides educational and research services. The institute offers services such as undergraduate courses, post graduate courses, international courses, accommodations, and libraries, among others. It conducts research in the areas of engineering and physical sciences, bio-medical and life sciences, and arts, humanities, and social sciences. Cardiff University offers courses in various disciplines including accounting, history, language, archaeology, architecture, astrophysics, banking and finance, biology, bio-medical science, biotechnology, business management, chemistry, civil engineering, computer science, criminology, dentistry, ecology, environment, geology, and others. The institute operates in Cardiff and Wales, the UK. Cardiff University is headquartered in Cardiff, the UK.

Cardiff University – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Cardiff University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Cardiff University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Cardiff University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Cardiff University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Cardiff University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Cardiff University, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Diamyd Medical Enters into Partnership with Cardiff University 10
Licensing Agreements 11
Tiziana Life Sciences Enters into Licensing Agreement with Cardiff University 11
Cancer Research Technology, Cardiff University, And Institute of Cancer Research Extend Licensing Agreement With Merck Serono 12
Cardiff University – Key Competitors 14
Cardiff University – Key Employees 15
Cardiff University – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 18
Government and Public Interest 18
Nov 17, 2017: Improved method of engineering T-cells to attack cancer 18
Aug 31, 2016: Potential New Treatment for Cocaine Addiction 19
Jul 07, 2016: Grant funding received to explore Midatech’s gold nanoparticle technology in immunotherapy 20
Jul 07, 2016: Midatech Pharma: Grant funding received to explore Midatech’s gold nanoparticle technology in immunotherapy 21
May 05, 2016: Drug combination could help reduce risk of death in type 2 diabetes 22
Jan 13, 2016: Upgrading the immune system : Cardiff University 23
Jan 06, 2016: In a step toward personalized drug testing, researchers coax human stem cells to form complex tissues 24
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Cardiff University, Pharmaceuticals & Healthcare, Key Facts 2
Cardiff University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Cardiff University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Cardiff University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Cardiff University, Deals By Therapy Area, 2011 to YTD 2017 8
Cardiff University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Diamyd Medical Enters into Partnership with Cardiff University 10
Tiziana Life Sciences Enters into Licensing Agreement with Cardiff University 11
Cancer Research Technology, Cardiff University, And Institute of Cancer Research Extend Licensing Agreement With Merck Serono 12
Cardiff University, Key Competitors 14
Cardiff University, Key Employees 15
Cardiff University, Other Locations 16
Cardiff University, Subsidiaries 17

★海外企業調査レポート[Cardiff University-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Attana AB-製薬・医療分野:企業M&A・提携分析
    Summary Attana AB (Attana) develops, manufactures and markets reagent kits and chip surfaces. The company offers products such as instruments, chip surfaces, reagents, kits and consumables; softwares, and accessories and spare parts. Its services comprise contract research, instrument training, atta …
  • Russian Standard Bank:企業の戦略・SWOT・財務情報
    Russian Standard Bank - Strategy, SWOT and Corporate Finance Report Summary Russian Standard Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Braskem SA (BRKM5):企業の財務・戦略的SWOT分析
    Braskem SA (BRKM5) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Zecotek Photonics Inc (ZMS):医療機器:M&Aディール及び事業提携情報
    Summary Zecotek Photonics Inc. (Zecotek) is a photonics technology company that focuses on developing advanced materials and integrated optoelectronic devices for optical precision surgery, high resolution medical imaging and biopharmaceutical research. It develops and sells scintillation crystals, …
  • Petroleo Brasileiro SA (PETR4)-エネルギー分野:企業M&A・提携分析
    Summary Petroleo Brasileiro S.A. (Petrobras) is an integrated oil and gas company. Its major businesses include exploration and production, refining, marketing , trade and transportation of oil and gas. The company also conducts biofuel, petrochemical, natural gas, electricity and chemical-gas busin …
  • Chevron Nigeria Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Chevron Nigeria Ltd (Chevron Nigeria) a subsidiary of Chevron Corporation is an oil and gas company that offers exploration, production and transportation of crude oil and natural gas. The company distributes products such as additives, jet fuels, base oil, chemical, fuel, lubricant, marine …
  • The Goodyear Tire & Rubber Company:企業の戦略・SWOT・財務情報
    The Goodyear Tire & Rubber Company - Strategy, SWOT and Corporate Finance Report Summary The Goodyear Tire & Rubber Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Pinnacle Entertainment Inc:企業のM&A・事業提携・投資動向
    Pinnacle Entertainment Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Pinnacle Entertainment Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Tec-Masters, Inc.:企業の戦略・SWOT・財務情報
    Tec-Masters, Inc. - Strategy, SWOT and Corporate Finance Report Summary Tec-Masters, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Diffusion Pharmaceuticals Inc (DFFN):製薬・医療:M&Aディール及び事業提携情報
    Summary Diffusion Pharmaceuticals Inc (Diffusion), formerly Diffusion Pharmaceuticals LLC is a clinical stage biotechnology company that develops standard of care therapies. The company improves cancer treatments such as radiation therapy and chemotherapy in treatment-resistant solid tumors, includi …
  • Telecom Plus plc (TEP):企業の財務・戦略的SWOT分析
    Telecom Plus plc (TEP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Everist Genomics Inc-医療機器分野:企業M&A・提携分析
    Summary Everist Genomics Inc (Everest Health), formerly Genetics Squared Inc is a developer of prognostics, medical diagnostic and therapeutic selection technologies. The company provides angiodefender cardiovascular disease diagnostic system, a non invasive device that is used for combining sensor …
  • AiCuris GmbH & Co KG-製薬・医療分野:企業M&A・提携分析
    Summary AiCuris GmbH & Co KG (AiCuris), a subsidiary of Santo Holding AG is a drug development company that discovers and develops antibacterial and antiviral agents for the treatment of life-threatening infectious diseases. The company’s pipeline products include antiviral and antibacterial agents …
  • Vascutek Ltd:製品パイプライン分析
    Summary Vascutek Ltd (Vascutek), a subsidiary of Terumo Corp is a medical equipment company that designs, manufactures and distributes vascular and cardiovascular products. The company provides products such as stent graft system, aortic root designs, polyester products and EPTFE products, among oth …
  • Intuit Inc.:企業の戦略・SWOT・財務情報
    Intuit Inc. - Strategy, SWOT and Corporate Finance Report Summary Intuit Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Orbotech Ltd. (ORBK):企業の財務・戦略的SWOT分析
    Orbotech Ltd. (ORBK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • SMU S.A. (SMU):企業の財務・戦略的SWOT分析
    SMU S.A. (SMU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • OncoSec Medical Inc (ONCS):企業の財務・戦略的SWOT分析
    Summary OncoSec Medical Inc (OncoSec) is a biotechnology company. The company offers services to stimulate body’s immune system and attack cancer. Its lead candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor th …
  • IXYS, LLC:企業の戦略的SWOT分析
    IXYS, LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Chiltern International Inc-製薬・医療分野:企業M&A・提携分析
    Summary Chiltern International Inc (Chiltern) is a contract research organization that provides clinical trial development services. It conducts clinical trials for medical devices, drugs, and diagnostics across all stages of development. The company offer wide range of services including clinical d …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆